Orgenesis (ORGS)
(Delayed Data from NSDQ)
$0.81 USD
-0.12 (-12.38%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $0.80 -0.01 (-1.83%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
ORGS 0.81 -0.12(-12.38%)
Will ORGS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ORGS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for ORGS
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
Orgenesis Announces Strategic Partnership with Harley Street Healthcare Group to Launch a State-of-the-Art Longevity & Wellness Initiative Globally
Orgenesis announces JV partnership with Harley Street Healthcare Group
Why Rumble Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket